Clinical Trial Update: A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D) [Phase 3]

View source ↗

Summary

Ongoing Phase 3 study evaluating oral eluxadoline in pediatric participants with irritable bowel syndrome with diarrhea (IBS-D); AbbVie is enrolling by invitati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Viberzi (eluxadoline)

Snippet

Sponsor: AbbVie | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: ENROLLING_BY_INVITATION